Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116143780B reveals high efficiency spiro compounds. Improves OLED lifespan and voltage. Reliable supplier for electronic chemical manufacturing.
Advanced synthesis of chiral bis[N,O] cyclopalladium complexes via patent CN108658802A. Offers high yield, cost reduction, and scalable manufacturing for fine chemical intermediates.
Patent CN105130982A reveals efficient synthesis route. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing with high purity.
Patent CN110156623A reveals buffer base method enhancing purity and yield for scalable contrast agent manufacturing supply chains significantly reducing impurity levels effectively for global buyers seeking stability now.
Patent CN102351777A details a novel organocatalytic route for chiral oxindoles. This report analyzes the cost-effective, metal-free synthesis for pharmaceutical intermediates.
Novel heterogeneous catalytic route for menthone production offering high TON and mild conditions, ensuring cost-effective supply chain solutions for flavor and fragrance industries.
Patent CN105315167A reveals a one-step chiral synthesis. This method offers high selectivity and cost reduction for pharmaceutical intermediate manufacturing supply chains.
Advanced catalytic method for paroxetine intermediate synthesis. Enhances optical purity and supply chain reliability for global pharmaceutical manufacturing partners.
Novel bioenzymatic route for high-purity pseudouridine. Reduces cost and environmental impact for pharmaceutical intermediates manufacturing.
Novel ruthenium-catalyzed visible light method for gamma-hydroxy ketones offers mild conditions and high atom economy for pharma intermediates.
Novel ruthenium-catalyzed visible light method for gamma-hydroxy ketones offers mild conditions and high atom economy for pharma intermediates.
Patent CN102978249A details a single-enzyme biocatalytic route for statin intermediates. Achieve >99% ee with simplified workup and reduced manufacturing costs.
Patent CN102925501A details a high-efficiency enzymatic route for statin intermediates, offering superior purity and scalable manufacturing capabilities for global supply chains.
Patent CN102040584A reveals a high-selectivity hydrogenation route for DCH18C6, offering significant cost reduction in specialty chemical manufacturing through simplified purification.
Advanced Gastrodin manufacturing via phase-transfer catalysis ensures high purity and cost efficiency. A robust solution for pharmaceutical intermediate supply chains.
Patent CN102516329B details a safer Gastrodin synthesis using phase-transfer catalysis, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115948357A reveals novel ketoreductase mutants for eslicarbazepine production, offering superior stereoselectivity and cost-effective biocatalytic manufacturing solutions.
Patent CN104693057A details high-purity 2,5-diaminoterephthalic acid production. Offers cost reduction and supply chain reliability for polymer manufacturing.
Patent CN101723892B reveals LTA catalysis for high-purity pharmaceutical intermediates. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Novel one-pot synthesis reduces cost and improves purity for electronic chemical manufacturing supply chains using advanced catalytic protocols.